Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-02

Clinical Trial Update: Fluphenazine Hydrochloride for Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fluphenazine hydrochloride for psoriasis has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

Sponsor: Tufts Medical Center | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2016-08-02